{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:46:06Z","timestamp":1776674766773,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13193-025-02394-6","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:57:49Z","timestamp":1754369869000},"page":"721-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of Oncological Outcomes between Trimodal Therapy and Radical Cystectomy in Patients with Variant Bladder Cancer"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8921-4571","authenticated-orcid":false,"given":"Aykut","family":"Demirci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuncel","family":"Uzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2394_CR1","unstructured":"Ferlay J, Ervik M, Lam F, LaveRCanne M, Colombet M, Mery L et al (2024) Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from:  https:\/\/gco.iarc.who.int\/today  Accessed 24 Apr 2024"},{"issue":"3","key":"2394_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.canep.2013.02.002","volume":"37","author":"F Abdollah","year":"2013","unstructured":"Abdollah F, Gandaglia G, Thuret R, Schmitges J, Tian Z, Jeldres C et al (2013) Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiol 37(3):219\u2013225","journal-title":"Cancer Epidemiol"},{"key":"2394_CR3","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.5489\/cuaj.1195","volume":"3","author":"V Chalasani","year":"2009","unstructured":"Chalasani V, Chin JL, Izawa JI (2009) Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 3:S193\u2013S198","journal-title":"Can Urol Assoc J"},{"issue":"20","key":"2394_CR4","first-page":"e23","volume":"33","author":"KR Rice","year":"2015","unstructured":"Rice KR, Koch MO, Kao CS, Pedrosa JA, Kaimakliotis HZ, MasteRCon TA et al (2015) Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology. Urol Oncol 33(20):e23\u2013e29","journal-title":"Urol Oncol"},{"key":"2394_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.juro.2012.10.054","volume":"189","author":"A Abd El-Latif","year":"2013","unstructured":"Abd El-Latif A, Watts KE, Elson P, Fergany A, Hansel DE (2013) The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. J Urol 189:1263\u20131267","journal-title":"J Urol"},{"key":"2394_CR6","doi-asserted-by":"crossref","unstructured":"Weizer AZ, Wasco MJ, Wang R, Daignault S, Lee CT, Shah RB (2009) Multiple adverse histological features increase the odds of under staging T1 bladder cancer [published correction appears in J Urol. 2009 Sep;182(3):1237]. J Urol 182(1):59\u201365","DOI":"10.1016\/j.juro.2009.02.116"},{"issue":"2","key":"2394_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.eururo.2019.09.035","volume":"77","author":"JA Witjes","year":"2020","unstructured":"Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M et al (2020) EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort\u2020: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol 77(2):223\u2013250","journal-title":"Eur Urol"},{"issue":"3","key":"2394_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11912-011-0161-4","volume":"13","author":"F Pons","year":"2011","unstructured":"Pons F, Orsola A, Morote J, Bellmunt J (2011) Variant forms of bladder cancer: basic considerations on treatment approaches. Curr Oncol Rep 13(3):216\u2013221","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2394_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO Classification of TumouRC of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumouRC. Eur Urol 70(1):93\u2013105","journal-title":"Eur Urol"},{"key":"2394_CR10","unstructured":"EAU Guidelines (2025) Edn. presented at the EAU annual congress Madrid\u00a0"},{"issue":"1","key":"2394_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clgc.2020.07.011","volume":"19","author":"M Deuker","year":"2021","unstructured":"Deuker M, Martin T, Stolzenbach F, Rosiello G, Coll\u00e0 Ruvolo C, Nocera L et al (2021) Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities. Clin Genitourin Cancer 19(1):60-68.e1","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"2394_CR12","doi-asserted-by":"publisher","first-page":"275.e1","DOI":"10.1016\/j.urolonc.2022.02.004","volume":"40","author":"F DuRCun","year":"2022","unstructured":"DuRCun F, Elshabrawy A, Wang H, Wu S, Liss MA, Kaushik D et al (2022Jun) Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy. Urol Oncol 40(6):275.e1-275.e10","journal-title":"Urol Oncol"},{"key":"2394_CR13","doi-asserted-by":"crossref","unstructured":"Pyrgidis N, Sokolakis I, Haltmair G, Hatzichristodoulou G (2023) The perioperative and long-term outcomes of patients with variant histology bladder cancer undergoing radical cystectomy: A propensity score-matched analysis with pure urothelial carcinoma. Actas Urol Esp (Engl Ed) 47(10):645\u2013653. English, Spanish","DOI":"10.1016\/j.acuroe.2023.06.007"},{"issue":"5","key":"2394_CR14","doi-asserted-by":"publisher","first-page":"161.e1","DOI":"10.1016\/j.urolonc.2024.01.009","volume":"42","author":"P Ramos","year":"2024","unstructured":"Ramos P, Mateus A, Manso M, Botelho F, Silva A, Silva J et al (2024) Prognostic impact of variant histology in bladder cancer: would early and aggressive treatment shift the paradigm? Urol Oncol 42(5):161.e1-161.e8","journal-title":"Urol Oncol"},{"issue":"11","key":"2394_CR15","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1002\/cam4.1684","volume":"7","author":"HY Lin","year":"2018","unstructured":"Lin HY, Ye H, Kernen KM, Hafron JM, Krauss DJ (2018) National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging. Cancer Med 7(11):5370\u20135381","journal-title":"Cancer Med"},{"issue":"1","key":"2394_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.eururo.2016.12.002","volume":"72","author":"RE Krasnow","year":"2017","unstructured":"Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S et al (2017) Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodal Bladder-sparing Therapy. Eur Urol 72(1):54\u201360","journal-title":"Eur Urol"},{"issue":"4","key":"2394_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.eururo.2023.05.005","volume":"84","author":"A Bamias","year":"2023","unstructured":"Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A et al (2023) Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty. Eur Urol 84(4):381\u2013389","journal-title":"Eur Urol"},{"issue":"1","key":"2394_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA et al (2024) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol 85(1):17\u201331","journal-title":"Eur Urol"},{"issue":"3","key":"2394_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12022-016-9444-5","volume":"27","author":"E Kouba","year":"2016","unstructured":"Kouba E, Cheng L (2016) Neuroendocrine tumors of the urinary bladder according to the 2016 World Health Organization classification: molecular and clinical characteristics. Endocr Pathol 27(3):188\u2013199. https:\/\/doi.org\/10.1007\/s12022-016-9444-5","journal-title":"Endocr Pathol"},{"issue":"3","key":"2394_CR20","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1016\/j.clgc.2016.09.005","volume":"15","author":"K Jung","year":"2017","unstructured":"Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE et al (2017) Small-cell carcinoma of the bladder: 20-year single-institution retrospective review. Clin Genitourin Cancer 15(3):e337\u2013e343. https:\/\/doi.org\/10.1016\/j.clgc.2016.09.005","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"2394_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.urolonc.2014.01.020","volume":"32","author":"DL Willis","year":"2014","unstructured":"Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA et al (2014) Micropapillary bladder cancer: current treatment patterns and review of the literature. Urol Oncol 32(6):826\u2013832. https:\/\/doi.org\/10.1016\/j.urolonc.2014.01.020","journal-title":"Urol Oncol"},{"issue":"7","key":"2394_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.humpath.2009.01.001","volume":"40","author":"A Lopez-Beltran","year":"2009","unstructured":"Lopez-Beltran A, Requena MJ, Montironi R, Blanca A, Cheng L (2009) Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol 40(7):1023\u20131028. https:\/\/doi.org\/10.1016\/j.humpath.2009.01.001","journal-title":"Hum Pathol"},{"issue":"1","key":"2394_CR23","doi-asserted-by":"publisher","first-page":"107327481880026","DOI":"10.1177\/1073274818800269","volume":"25","author":"A Minato","year":"2018","unstructured":"Minato A, Noguchi H, Tomisaki I, Fukuda A, Kubo T, Nakayama T et al (2018) Clinical significance of squamous differentiation in urothelial carcinoma of the bladder. Cancer Control 25(1):1073274818800269. https:\/\/doi.org\/10.1177\/1073274818800269","journal-title":"Cancer Control"},{"issue":"3","key":"2394_CR24","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1200\/JCO.1997.15.3.1022","volume":"15","author":"LA Kachnic","year":"1997","unstructured":"Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL et al (1997) Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15(3):1022\u20131029. https:\/\/doi.org\/10.1200\/JCO.1997.15.3.1022","journal-title":"J Clin Oncol"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02394-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-025-02394-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02394-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:56:21Z","timestamp":1776671781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-025-02394-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2394"],"URL":"https:\/\/doi.org\/10.1007\/s13193-025-02394-6","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"value":"0975-7651","type":"print"},{"value":"0976-6952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}